IMPROVED PROGNOSIS OF DIFFUSE HISTIOCYTIC AND UNDIFFERENTIATED LYMPHOMA BY USE OF HIGH-DOSE METHOTREXATE ALTERNATING WITH STANDARD AGENTS (M-BACOD)

被引:360
作者
SKARIN, AT
CANELLOS, GP
ROSENTHAL, DS
CASE, DC
MACINTYRE, JM
PINKUS, GS
MOLONEY, WC
FREI, E
机构
[1] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
[2] MAINE MED CTR, PORTLAND, ME 04102 USA
关键词
D O I
10.1200/JCO.1983.1.2.91
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:91 / 98
页数:8
相关论文
共 51 条
[1]  
ARMITAGE JO, 1980, CANCER TREAT REP, V64, P649
[2]  
BAUER BA, AM J MED
[3]   CLINICAL-PHARMACOLOGY OF METHOTREXATE [J].
BERTINO, JR .
MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (04) :401-411
[4]   PROTECTED ENVIRONMENT PROPHYLACTIC ANTIBIOTIC PROGRAM FOR MALIGNANT-LYMPHOMA - RANDOMIZED TRIAL DURING CHEMOTHERAPY TO INDUCE REMISSION [J].
BODEY, GP ;
RODRIGUEZ, V ;
CABANILLAS, F ;
FREIREICH, EJ .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (01) :74-81
[5]  
BONADONNA G, 1977, CANCER TREAT REP, V61, P1117
[6]  
BUNN PA, 1976, BLOOD, V47, P3
[7]   FACTORS PREDICTING FOR RESPONSE AND SURVIVAL IN ADULTS WITH ADVANCED NON-HODGKINS LYMPHOMA [J].
CABANILLAS, F ;
BURKE, JS ;
SMITH, TL ;
MOON, TE ;
BUTLER, JJ ;
RODRIGUEZ, V .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) :413-418
[8]  
CADMAN E, 1977, CANCER TREAT REP, V61, P1109
[9]  
CANELLOS GP, 1979, 1978 INT S CNS COMPL, P142
[10]  
CARBONE PP, 1971, CANCER RES, V31, P1860